Showing 1,101 - 1,120 results of 37,314 for search 'CJ7~', query time: 1.50s Refine Results
  1. 1101

    Odpowiedź na pracę dr. Pawła E. Tomaszewskiego pt. „Komentarz do artykułu Mariusza W. Majewskiego opublikowanego w Studia Historiae Scientiarum 17 (2018), ss. 89–117 by Mariusz W. Majewski

    Published 2019-11-01
    “…Majewski published in Studia Historiae Scientiarum 17 (2018), pp. 89–117” Abstract The article is a response to the polemical commentary by Paweł E. …”
    Get full text
    Article
  2. 1102

    Principles of medicine in Africa /

    Published 2013
    Subjects: “…Public Health Practice Africa. 457…”
    View in OPAC
    Book
  3. 1103

    Care of the Critically ill Patient in the Tropics and Sub-tropics /

    Published 1991
    Subjects: “…Critical care medicine. 317…”
    View in OPAC
    Book
  4. 1104

    Understanding Pharmacology : essentials for medication safety / by Workman, M. Linda

    Published 2011
    Subjects:
    View in OPAC
    Book
  5. 1105
  6. 1106
  7. 1107
  8. 1108
  9. 1109
  10. 1110
  11. 1111
  12. 1112
  13. 1113
  14. 1114

    بررسی تأثیر زمان و مقادیر محلول پاشی متانول بر عملکرد کمی و کیفی توتون گرم‌خانه‌ای رقم کوکر 347 در منطقه احمد گوراب رشت

    Published 2012-07-01
    “…به‌منظور بررسی اثر متانول بر رشد و عملکرد گیاه توتون ویرجینیا رقم کوکر ۳۴۷ آزمایشی در سال زراعی 88-1387 به‌صورت آزمایش فاکتوریل در قالب طرح کاملاً تصادفی در ۴ تکرار به اجرا در آمد. …”
    Get full text
    Article
  15. 1115

    The Duchess of Malfi de John Webster ou le corps dans tous ses états: « Some said he was an hermaphrodite, for he could not abide a woman » (3. 2. 217-218) by Laetitia Coussement-Boillot

    Published 2019-01-01
    “…In The Duchess of Malfi, Webster stages the Duchess’s pregnant body (1.1), the Duchess gorging on apricots (2.1), the Duchess kissing a cut-off hand (4.1), the wax effigies of Antonio and the children’s dead bodies (4.1). …”
    Get full text
    Article
  16. 1116

    Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial by Gang Chen, Dong-Chen Sun, Yi Ba, Ya-Xiong Zhang, Ting Zhou, Yuan-Yuan Zhao, Hong-Yun Zhao, Wen-Feng Fang, Yan Huang, Zhen Wang, Chao Deng, De-Sheng Hu, Wei Wang, Jin-Guan Lin, Gui-Ling Li, Su-Xia Luo, Zhi-Chao Fu, Hai-Sheng Zhu, Hui-Li Wang, Sheng-Li Cai, Xiao-Qiang Kang, Li Zhang, Yun-Peng Yang

    Published 2025-02-01
    “…In immunotherapy-naive NPC patients (n = 12), ORR was 33.3%, disease control rate (DCR) was 75%, and median progression-free survival (PFS) was 10.8 months (95% CI, 1.3 to not estimated). In IO-treated NPC patients (n = 17), ORR was 11.8%, DCR was 64.7%, and median PFS was 2.7 months (95% CI, 1.4 to 4.9). …”
    Get full text
    Article
  17. 1117
  18. 1118
  19. 1119
  20. 1120